SWAN Capital LLC

Position in PFE — Pfizer Inc

CIK 1952722 PENSACOLA, FL

Position in PFE

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$268,997

-$61,055 QoQ

Shares Held

11,171

-5.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.46%

of 13F equity value

Holder Rank

#2,208

of 2,821 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SWAN Capital LLC holds $786,866 across 10 Drug Manufacturers - General names. PFE ranks #2 (34.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	240	$287,863
2	PFE	Pfizer Inc This page	11,171	$268,997
3	JNJ	Johnson & Johnson	556	$141,207
4	MRK	Merck & Co., Inc.	482	$61,937
5	BMY	Bristol Myers Squibb Co	148	$8,527
6	ABBV	AbbVie Inc.	23	$5,787
7	GSK	GSK plc	89	$4,665
8	NVO	Novo Nordisk A S	95	$4,554

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$268,997	11,171	-5.0%	Shares	Sole	2026-08-13
2026-03-31	$330,052	11,754	+3.8%	Shares	Sole	2026-05-14
2025-12-31	$281,843	11,319	-0.4%	Shares	Sole	2026-02-12
2025-09-30	$289,682	11,369	+0.0%	Shares	Sole	2025-11-14
2025-06-30	$275,536	11,367	+0.0%	Shares	Sole	2025-08-14
2025-03-31	$288,014	11,366	+0.0%	Shares	Sole	2025-05-23
2024-12-31	$301,513	11,365	+2.4%	Shares	Sole	2025-02-25
2024-09-30	$321,291	11,102	0.0%	Shares	Sole	2024-11-14
2024-06-30	$310,633	11,102	+0.3%	Shares	Sole	2024-08-14
2024-03-31	$307,303	11,074	+2.5%	Shares	Sole	2024-04-30
2023-12-31	$310,989	10,802	+4.5%	Shares	Sole	2024-02-13
2023-09-30	$342,911	10,338	—	Shares	Sole	2023-10-19
No filing history on record for this holder in this stock.